CBD Market
JM Wholesale sees 750 products included on FSA CBD list
The CBD stockist has described the development as a milestone for the company.
Stephanie Price
July 6, 2022
The CBD stockist has described the development as a milestone for the company.
With the CBD market getting more saturated with not only the influx of CBD, but different variations of skin care
Columbia Care is to be acquired by Cresco Labs in a deal which will create the world’s “largest cannabis company
SEED Innovations vice president of investment analysis discusses how the cannabis industry has developed and the growing opportunities in Europe.
Voyager has acquired the companies after parent company Cannafull Ltd recently went into liquidation.
The products are set to be made available to patients in the coming weeks
The long-awaited MoU will ensure that the Bailiwick is at the forefront of the developing cannabis sector
Tej Virk is appointed as CEO of Akanda as Halo Collective reorganises its international assets into the newly formed company
The 63% acquisition will see a further investment of £5.25m to help fund the growth of the business
The partnership will help to accelerate and advance research for both cannabis and psychedelics.
The announcement marks the launch of Cannaray’s “Join the CBD Revolution” national outdoor and digital advertising campaign.
The Apollon medical cannabis formulations are an opportunity for more men to have their prostate cancer treated.
MGC Pharma anticipates that the patent for its novel SNEDDS formulation will be issued within the coming 12 months.
CanCoin, a new token that utilises blockchain technology, has been launched to accelerate the European cannabis industry.
The first cannabis company to IPO on LSE, Kanabo, has launched a new extract formula that will give thousands of UK patients access to pain relief in a metered dose.
Stakeholders from across the sector have set out their agenda for creating a more robust UK industry
Oxford Cannabinoid Technologies has signed a deal with drug development firm Evotec as it moves towards Phase 1 clinical trials
It’s been described as a “historic” moment for the sector.
We won’t spam you